Seres Therapeutics, Inc.
Posted on: July 19, 2021
By: Kim Berlowitz
With: Comments Off on Seres Therapeutics, Inc.
MTS served as the exclusive financial advisor to Seres Therapeutics on its co-commercialization license agreement with Nestlé Health Science for SER-109